QuantiFERON-TB Gold Plus - Business-News-Today.com

Business-News-Today.com

Business news, market intelligence, and global industry analysis.

Business-News-Today.com

The Latest

Can fewer infusions improve adherence in Fabry disease enzyme replacement therapy?

CVS stock slips as Aetna settles Medicare Advantage diagnosis code fraud case for $117.7m

What the Mount Raymond acquisition means for SLAM Exploration Ltd.’s Goodwin project scale (TSXV: SXL)

CVGI surges 54% as CVG names Zoox strategic supplier and issues $700M revenue outlook for 2026

QIAGEN files lawsuit against bioMérieux to defend QuantiFERON patents and innovation in tb diagnostics

Read More

4 minute read

Pharma Industry News

QIAGEN files lawsuit against bioMérieux to defend QuantiFERON patents and innovation in TB diagnostics

QIAGEN N.V. (NYSE: QGEN; Frankfurt Prime Standard: QIA) has initiated legal proceedings against bioMérieux S.A. (EPA: BIM) in…

byPallavi Madhiraju

March 3, 2025

web analytics